TY - JOUR
T1 - Building a biofoundry
AU - Holowko, Maciej B.
AU - Frow, Emma K.
AU - Reid, Janet C.
AU - Rourke, Michelle
AU - Vickers, Claudia E.
N1 - Funding Information:
M.B.H. and M.R. acknowledge support from CSIRO's Synthetic Biology Future Science Platform. E.K.F. acknowledges research support from the European Research Council [EC 616510 ENLIFE].
Publisher Copyright:
© 2020 Crown copyright 2020.
PY - 2021
Y1 - 2021
N2 - A biofoundry provides automation and analytics infrastructure to support the engineering of biological systems. It allows scientists to perform synthetic biology and aligned experimentation on a high-throughput scale, massively increasing the solution space that can be examined for any given problem or question. However, establishing a biofoundry is a challenging undertaking, with numerous technical and operational considerations that must be addressed. Using collated learnings, here we outline several considerations that should be addressed prior to and during establishment. These include drivers for establishment, institutional models, funding and revenue models, personnel, hardware and software, data management, interoperability, client engagement and biosecurity issues. The high cost of establishment and operation means that developing a long-term business model for biofoundry sustainability in the context of funding frameworks, actual and potential client base, and costing structure is critical. Moreover, since biofoundries are leading a conceptual shift in experimental design for bioengineering, sustained outreach and engagement with the research community are needed to grow the client base. Recognition of the significant, long-term financial investment required and an understanding of the complexities of operationalization is critical for a sustainable biofoundry venture. To ensure state-of-the-art technology is integrated into planning, extensive engagement with existing facilities and community groups, such as the Global Biofoundries Alliance, is recommended.
AB - A biofoundry provides automation and analytics infrastructure to support the engineering of biological systems. It allows scientists to perform synthetic biology and aligned experimentation on a high-throughput scale, massively increasing the solution space that can be examined for any given problem or question. However, establishing a biofoundry is a challenging undertaking, with numerous technical and operational considerations that must be addressed. Using collated learnings, here we outline several considerations that should be addressed prior to and during establishment. These include drivers for establishment, institutional models, funding and revenue models, personnel, hardware and software, data management, interoperability, client engagement and biosecurity issues. The high cost of establishment and operation means that developing a long-term business model for biofoundry sustainability in the context of funding frameworks, actual and potential client base, and costing structure is critical. Moreover, since biofoundries are leading a conceptual shift in experimental design for bioengineering, sustained outreach and engagement with the research community are needed to grow the client base. Recognition of the significant, long-term financial investment required and an understanding of the complexities of operationalization is critical for a sustainable biofoundry venture. To ensure state-of-the-art technology is integrated into planning, extensive engagement with existing facilities and community groups, such as the Global Biofoundries Alliance, is recommended.
KW - biofoundry
KW - high-throughput
KW - synthetic biology
UR - http://www.scopus.com/inward/record.url?scp=85104862448&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=85104862448&partnerID=8YFLogxK
U2 - 10.1093/synbio/ysaa026
DO - 10.1093/synbio/ysaa026
M3 - Article
AN - SCOPUS:85104862448
SN - 1939-7267
VL - 6
JO - Synthetic Biology
JF - Synthetic Biology
IS - 1
M1 - ysaa026
ER -